Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Anaptysbio (ANAB) Leases (2019 - 2025)

Anaptysbio filings provide 7 years of Leases readings, the most recent being $12.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 12.96% year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2025, down 12.96%, and an annual FY2025 reading of $12.5 million, down 12.96% over the prior year.
  • Leases hit $12.5 million in Q4 2025 for Anaptysbio, down from $13.0 million in the prior quarter.
  • The five-year high for Leases was $20.3 million in Q2 2021, with the low at $218000.0 in Q1 2021.
  • Median Leases over the past 5 years was $16.4 million (2023), compared with a mean of $15.7 million.
  • The sharpest move saw Leases tumbled 82.03% in 2021, then surged 8683.03% in 2022.
  • Year by year, Leases stood at $19.6 million in 2021, then fell by 8.49% to $17.9 million in 2022, then decreased by 9.63% to $16.2 million in 2023, then fell by 11.07% to $14.4 million in 2024, then dropped by 12.96% to $12.5 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $12.5 million, $13.0 million, and $13.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.